Pfizer: Diabetic Neuropathies trials
The registry lists 10 Diabetic Neuropathies studies with Pfizer as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 4Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)CompletedNCT02215252Phase 2Results posted
- A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral NeuropathyTerminatedNCT01087203Phase 2Results posted
- Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral NeuropathyTerminatedNCT01050218Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal WomenCompletedNCT00369343Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral NeuropathyTerminatedNCT00283842Phase 3Results posted
- A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.TerminatedNCT00625833Phase 2
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 PathwayCompletedNCT00456898Phase 1
- To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.CompletedNCT00150423Phase 3
- Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.CompletedNCT00141401Phase 3
- Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic NeuropathyTerminatedNCT00073034Phase 2